For CSF neurodegenerative biomarkers, Alzheimer’s disease cohorts were extensively studied, and tau and amyloid β correlate with DTI parameters in opposite directions. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.